NO980546D0 - Farmasöytiske midler - Google Patents

Farmasöytiske midler

Info

Publication number
NO980546D0
NO980546D0 NO980546A NO980546A NO980546D0 NO 980546 D0 NO980546 D0 NO 980546D0 NO 980546 A NO980546 A NO 980546A NO 980546 A NO980546 A NO 980546A NO 980546 D0 NO980546 D0 NO 980546D0
Authority
NO
Norway
Prior art keywords
pharmaceutical agents
pharmaceutical
agents
Prior art date
Application number
NO980546A
Other languages
English (en)
Other versions
NO980546L (no
Inventor
Mitchell Irvin Steinberg
Fatima Emitsel Yakubu-Madus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO980546D0 publication Critical patent/NO980546D0/no
Publication of NO980546L publication Critical patent/NO980546L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO980546A 1997-02-11 1998-02-09 Farmas°ytiske midler NO980546L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79866197A 1997-02-11 1997-02-11

Publications (2)

Publication Number Publication Date
NO980546D0 true NO980546D0 (no) 1998-02-09
NO980546L NO980546L (no) 1998-08-12

Family

ID=25173964

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980546A NO980546L (no) 1997-02-11 1998-02-09 Farmas°ytiske midler

Country Status (12)

Country Link
EP (1) EP0857483A1 (no)
JP (1) JPH10218773A (no)
KR (1) KR19980071226A (no)
AU (1) AU5387898A (no)
CA (1) CA2229123A1 (no)
CZ (1) CZ39398A3 (no)
HU (1) HUP9800291A2 (no)
IL (1) IL123232A0 (no)
MX (1) MX9801129A (no)
NO (1) NO980546L (no)
SG (1) SG76535A1 (no)
ZA (1) ZA981029B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044355A1 (en) * 1999-01-29 2000-08-03 Eli Lilly And Company Moxonidine salts
ITTV20010002U1 (it) 2001-01-12 2002-07-12 Vetraria Biancadese Sas Soc Tavolo avente almeno una prolunga estraibile mediante semplice rotazione
EP1599468B1 (en) 2003-01-14 2007-10-03 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US20070066590A1 (en) * 2003-02-24 2007-03-22 Jones Robert M Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
RU2362561C2 (ru) * 2003-10-10 2009-07-27 Зольвай Фармасьютиклз Гмбх Фармацевтическая композиция, включающая селективный агонист имидазолинового рецептора i1 и блокатор рецептора ангиотензина ii
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
WO2007090720A2 (en) * 2006-01-27 2007-08-16 F. Hoffmann-La Roche Ag Use of 2-imidazoles for the treatment of cns disorders
KR101176699B1 (ko) 2006-10-19 2012-08-23 에프. 호프만-라 로슈 아게 아미노메틸-4-이미다졸
WO2008052907A1 (en) 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles as modulators of the trace amine associated receptors
RU2456281C2 (ru) 2006-11-16 2012-07-20 Ф. Хоффманн-Ля Рош Аг Замещенные 4-имидазолы, способ их получения и их применение
WO2008071574A1 (en) 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
CA2675221C (en) 2007-02-02 2016-02-23 F. Hoffmann-La Roche Ag Novel 2-aminooxazolines as taar1 ligands
KR101335845B1 (ko) 2007-02-15 2013-12-02 에프. 호프만-라 로슈 아게 Ｔａａｒ1 리간드로서의 2-아미노옥사졸린
CN101687812A (zh) 2007-07-02 2010-03-31 弗·哈夫曼-拉罗切有限公司 对痕量胺相关受体(taar)具有良好亲和性的2-咪唑啉化合物
EP2173719A1 (en) 2007-07-03 2010-04-14 F. Hoffmann-Roche AG 4-imidazolines and their use as antidepressants
AU2008281918A1 (en) 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands
WO2009019149A1 (en) 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as taar1 ligands
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
AU2011305525B2 (en) 2010-09-22 2016-08-18 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
EP2829540A1 (en) 2013-07-26 2015-01-28 Abbott Healthcare Products B.V. Synthesis of substituted aminopyridines
CN116850181A (zh) 2015-01-06 2023-10-10 艾尼纳制药公司 治疗与s1p1受体有关的病症的方法
ES2929526T3 (es) 2015-06-22 2022-11-29 Arena Pharm Inc Sal cristalina de L-arginina del ácido (R)-2-(7-(4-ciclopentil-3-(trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para su uso en trastornos asociados al receptor S1P1
MA53755A (fr) 2016-03-17 2021-08-04 Hoffmann La Roche Dérivé de 5-éthyl-4-méthyl-pyrazole-3-carboxamide ayant une activité comme agonist de taar

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel

Also Published As

Publication number Publication date
NO980546L (no) 1998-08-12
CA2229123A1 (en) 1998-08-11
ZA981029B (en) 1999-08-10
HU9800291D0 (en) 1998-04-28
SG76535A1 (en) 2000-11-21
JPH10218773A (ja) 1998-08-18
CZ39398A3 (cs) 1998-08-12
KR19980071226A (ko) 1998-10-26
HUP9800291A2 (hu) 2001-02-28
MX9801129A (es) 1998-11-29
AU5387898A (en) 1998-08-13
IL123232A0 (en) 1999-11-30
EP0857483A1 (en) 1998-08-12

Similar Documents

Publication Publication Date Title
ID23874A (id) Obat
NO980546D0 (no) Farmasöytiske midler
ID24654A (id) Formulasi farmasi omeprazola
DE69831181D1 (de) Positionsbestimmung
DE69817568D1 (de) Elektrochemilumineszenzdetektor
DE69800755T2 (de) Strohbauplatte
DE69820407D1 (de) Blisterpackung
DK1017392T3 (da) Lægemiddel
IS5331A (is) Ný lyfjablanda
NO995147D0 (no) Kontrastmidler
NO994619D0 (no) Farmasöytiske blandinger
NO20003141D0 (no) Farmasøytiske blandinger
ATE236897T1 (de) 3-benzylpiperidine
ID23531A (id) Komposisi farmasi
NO995215D0 (no) Flersone-produksjonsovervÕkningssystem
FI973712A0 (fi) Visningselement
FI974274A0 (fi) Abonnentlinjekrets
ID21180A (id) Senyawa-senyawa farmasi
NO974138D0 (no) Kontrastmidler
BR1100755A (pt) composição farmacêutica
UA25523A (uk) Лікувальhий препарат гірчичhик
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
DE69721214D1 (de) Blisterverpackung
FR2771676B1 (fr) Livre
DK0969815T3 (da) Farmaceutiske præparater